The ultimate goal would be to create an "artificial stool", a consortium of commensal bacteria fermented and harvested in vitro,
A recent Cochrane review shows that probiotics appear to be effective and safe in preventing Clostridium difficile infection
27 Aug 2018by Paul Enck
A new systematic review and meta-analysis concludes that probiotics are associated with a lower risk of symptomatic C. difficile infection.
A review examines the role of dietary transition metals on host microbiota and risk of disease
12 Jul 2018by Andreu Prados
A new review focuses on mechanisms leading to increased susceptibility to bacterial infection in the context of interactions between dietary transition metals,
A diet rich in dietary plant polysaccharides suppresses Clostridium difficile infection in mice
10 May 2018by Andreu Prados
A new study has found that microbiota-accessible carbohydrate-utilizing bacteria and short-chain fatty acids generated during their fermentation prevent C. difficile infection perpetuation in mice.
Gut Microbiota for Health releases the first of two summary documents on gut microbiota and probiotics
29 Jan 2018by GMFH Editing Team
The scientific knowledge on probiotics is advancing very quickly—stay tuned for the second GMFH "best of probiotics" document.
A scientific committee chaired has taken care to put together a program that covers the most relevant issues in the field today.
Gut Microbiota Clinical Minute: Can probiotics prevent Clostridium difficile infection?
3 Jul 2017by Kristina Campbell
In the new Gut Microbiota for Health “Clinical Minute” series, we get a scientific expert’s take on gut-microbiota-related questions to healthcare professionals.
Most mucosal surfaces of the human body contain an extremely complex ecosystem of microbial organisms. These resident microbes exist in a delicate balance with each other and the human host that is dictated by the specific local environmental factors of each host body site. In health, the many different species that make up the microbiota exist in homeostasis with the host immune system. A dysbiosis of the microbiota shifts the community, which may lead to disease.
Gut microbiota signatures may predict how individuals respond to primary treatment for Clostridium difficile infection
28 Nov 2016by Andreu Prados
A recent study, led by Dr. Purna C. Kashyap from the Division of Gastroenterology and Hepatology at Mayo Clinic in Rochester (USA), has found that gut microbiota signatures may allow identification of patients with Clostridium difficile infection who will respond to initial treatment.
Fewer Surgeries for Clostridium difficile Infection after Implementation of FMT Program
6 Oct 2015by GMFH Editing Team
Between January 2010 and April 2015, 901 patients with CDI were identified, with a gradual increase over time (2010= 54 patients; 2011= 116 patients; 2012= 200 patients; 2013= 212 patients; 2014= 268 patients; January-April 2015= 71 patients). Thirty-five patients with severe cases underwent FMT: 7 in 2013, 16 in 2014, and 12 between January and April 2015.
